Anakinra in COVID-19: A step closer to the cure.

Barkas, Fotios; Christaki, Eirini; Liberopoulos, Evangelos; Kosmidou, Maria; Milionis, Haralampos

Barkas, Fotios; Christaki, Eirini; Liberopoulos, Evangelos; Kosmidou, Maria; Milionis, Haralampos.

Barkas F; Department of Internal Medicine, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece.
Christaki E; Department of Internal Medicine, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece.
Liberopoulos E; Department of Internal Medicine, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece.
Kosmidou M; Department of Internal Medicine, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece.
Milionis H; Department of Internal Medicine, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece. Electronic address: hmilioni@uoi.gr.

Eur J Intern Med ; 96: 113-114, 2022 02.

Article in English | MEDLINE | ID: covidwho-1509755

Subject(s)

COVID-19; Interleukin 1 Receptor Antagonist Protein; Humans; Respiration, Artificial; SARS-CoV-2; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Interleukin 1 Receptor Antagonist Protein / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Eur J Intern Med Journal subject: Internal Medicine Year: 2022 Document Type: Article Affiliation country: J.EJIM.2021.11.005

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google